# Suhexiang Pill for Acute Ischemic Stroke: A Registry Study

> **NCT05833932** · — · RECRUITING · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 1000 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Suhexiang Pill

## Key facts

- **NCT ID:** NCT05833932
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05833932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05833932, "Suhexiang Pill for Acute Ischemic Stroke: A Registry Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05833932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*